Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two bismuth quadruple regimens for first-line Helicobacter pylori eradication in adults with duodenal ulcer
TCTR20170623004Phase 2Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Oct 2014
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bismuth subcitrate, omeprazole, metronidazole, amoxicillin, tetracycline in Helicobacter pylori infection, duodenal ulcer, sponsored by Shahid Sadoughi University of Medical Sciences. Started Oct 2014; status: completed.
02
Drugs
bismuth subcitrateomeprazolemetronidazoleamoxicillintetracycline
03
Conditions
Helicobacter pylori infectionduodenal ulcer
Beyond the preview
Go deeper on TCTR20170623004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170623004.